These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34610996)

  • 1. ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases.
    Liu Y; Chen S; Yang G; Wang B; Lan J; Dai F; Rao P; Wu P; Qian H; Shi G
    Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34610996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
    Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
    J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.
    Liu Y; Chen S; Sun Y; Lin Q; Liao X; Zhang J; Luo J; Qian H; Duan L; Shi G
    Medicine (Baltimore); 2016 Dec; 95(50):e5565. PubMed ID: 27977588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
    Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
    Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.
    Pamuk ON; Ali SM; Hasni S
    Autoimmun Rev; 2023 Apr; 22(4):103297. PubMed ID: 36781038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status.
    Md Yusof MY; Psarras A; El-Sherbiny YM; Hensor EMA; Dutton K; Ul-Hassan S; Zayat AS; Shalbaf M; Alase A; Wittmann M; Emery P; Vital EM
    Ann Rheum Dis; 2018 Oct; 77(10):1432-1439. PubMed ID: 29929956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura.
    Zimmerman SA; Ware RE
    J Pediatr Hematol Oncol; 1997; 19(4):297-303. PubMed ID: 9256827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with secondary immune thrombocytopenia in patients with primary Sjögren's syndrome: a retrospective study of 639 cases.
    Luo J; Song WJ; Chen JQ; Yang GY; Yang JY; Yu XB; Huang ZW; Xu Y; Wang JM; Tao QW
    Clin Exp Rheumatol; 2022 Dec; 40(12):2245-2252. PubMed ID: 35383565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
    Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study.
    Du H; Su W; Su J; Hu J; Wu D; Long W; Zhu J
    Rheumatology (Oxford); 2024 Jan; 63(1):79-84. PubMed ID: 37079730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to dense-fine-speckled 70 (DFS70) do not necessarily rule out connective tissue diseases.
    Mockenhaupt LM; Dolscheid-Pommerich R; Stoffel-Wagner B; Behning C; Brossart P; Schäfer VS
    Semin Arthritis Rheum; 2022 Feb; 52():151936. PubMed ID: 35027246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases.
    Davis JM; Moder KG; Homburger HA; Ytterberg SR
    Medicine (Baltimore); 2005 Jul; 84(4):208-217. PubMed ID: 16010205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibodies in childhood immune thrombocytopaenia: An increased risk for development of autoimmune disorders?
    Kapur R
    Br J Haematol; 2023 Jul; 202(2):215-216. PubMed ID: 37006171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speckled antinuclear antibodies in keratinocytes--what does it mean?
    Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
    Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study.
    Sun F; Chen J; Wu W; Geng S; Xu W; Sun S; Chen Z; Gu L; Wang X; Li T; Ye S
    Clin Rheumatol; 2020 Oct; 39(10):3099-3104. PubMed ID: 32418039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
    Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
    Zhou EM; Shen H; Wang D; Xu W
    PeerJ; 2024; 12():e17152. PubMed ID: 38666084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.